Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 20

Results For "Max"

390 News Found

Croda signs supply deals with Amyris, BSI for vaccine adjuvants
News | May 21, 2023

Croda signs supply deals with Amyris, BSI for vaccine adjuvants

These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.


Envision Scientific receives IGBC Gold Certification for India factory
News | May 17, 2023

Envision Scientific receives IGBC Gold Certification for India factory

Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure


AiMeD welcomes Govt’s for assistance to medical devices clusters
Policy | May 16, 2023

AiMeD welcomes Govt’s for assistance to medical devices clusters

The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive


Sanofi India to demerge healthcare businesses
News | May 12, 2023

Sanofi India to demerge healthcare businesses

This decision will accelerate growth for both its pharma & consumer healthcare businesses in India


Evonik partners with Safic-Alcan to boost offering of advanced food ingredients
News | May 11, 2023

Evonik partners with Safic-Alcan to boost offering of advanced food ingredients

Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt


Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules
Drug Approval | April 24, 2023

Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules

Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels


SÜDPACK’s PharmaGuard blister concept to add to sustainability
News | April 21, 2023

SÜDPACK’s PharmaGuard blister concept to add to sustainability

SÜDPACK is setting standards in terms of both performance and sustainability


Vaniam appoints Paula Franson to lead Clinical Strategy & Solutions
People | April 18, 2023

Vaniam appoints Paula Franson to lead Clinical Strategy & Solutions

Franson will help biopharma clients design a phased approach to inform and execute clinical development plans


Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
News | April 17, 2023

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology